Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.24.3
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2022 $ 57 $ 310,171 $ (206,798) $ 103,430
Balance (in Shares) at Jun. 30, 2022 57,079      
Common stock issued for cash, net of issuance costs $ 12 32,013 32,025
Common stock issued for cash, net of issuance costs (in Shares) 12,546      
Stock-based compensation $ 1 9,406 9,407
Stock-based compensation (in Shares) 1,009      
ESPP purchase 560 560
ESPP purchase (in Shares) 89      
Common stock issued in acquisition $ 1 1,689 1,690
Common stock issued in acquisition (in Shares) 606      
Common stock issued in payment of note interest $ 1 2,683 2,684
Common stock issued in payment of note interest (in Shares) 826      
Net loss (63,557) (63,557)
Balance at Jun. 30, 2023 $ 72 356,522 (270,355) 86,239
Balance (in Shares) at Jun. 30, 2023 72,155      
Cumulative-effect adoption of ASU 2016-13 (201) (201)
Common stock issued services 91 91
Common stock issued services (in Shares) 120      
Common stock issued in exercise of warrants $ 8 7,266 7,274
Common stock issued in exercise of warrants (in Shares) 8,500      
Common stock issued for cash, net of issuance costs $ 34 12,307 12,341
Common stock issued for cash, net of issuance costs (in Shares) 33,500      
Stock-based compensation $ 1 2,847 2,848
Stock-based compensation (in Shares) 898      
ESPP purchase 66 66
ESPP purchase (in Shares) 287      
Common stock issued in payment of note interest $ 8 2,190 2,198
Common stock issued in payment of note interest (in Shares) 7,932      
Net loss (167,950) (167,950)
Balance at Jun. 30, 2024 $ 123 $ 381,289 $ (438,506) $ (57,094)
Balance (in Shares) at Jun. 30, 2024 123,392